Health Shenandoah Therapeutics Secures $21.5 Million for Cancer Research Shenandoah Therapeutics, a spinout from Stanford University, has successfully raised $21.5 million in its latest funding round aimed at advancing innovative cancer therapies. The... Editorial11 hours ago